Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

Are unlicensed feline coronavirus antiviral compounds GS-441524 and GC376 what they claim to be? A qualitative and quantitative analysis.

14 September 2023, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Feline infectious peritonitis (FIP) caused by feline coronavirus was, until recently, considered both fatal and untreatable. Experimental antivirals such as GS-441524 and GC376 can be obtained off-label through crowdsourced internet groups and have been used by pet owners to treat FIP. We describe analysis and characterization of unregulated batches of both GS-441524 and GC376

Keywords

Feline Infectious Peritonitis
FIP
GS-441524
GC376
Molnupiravir
EIDD
Feline Coronavirus
Remdesivir

Supplementary materials

Title
Description
Actions
Title
Supplemental Figures
Description
Are unlicensed feline coronavirus antiviral compounds GS-441524 and GC376 what they claim to be? A qualitative and quantitative analysis supplemental information.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Version History

Sep 14, 2023 Version 1

Metrics

1,149
973
0
Views
Downloads
Citations

License

CC logo
CC
BY logo
BY
NC logo
NC
ND logo
ND
The content is available under CC BY NC ND 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv-2023-jjwj7
D O I: 10.26434/chemrxiv-2023-jjwj7 [opens in a new tab]

Author’s competing interest statement

The author(s) have declared they have no conflict of interest with regard to this content

Ethics

The author(s) have declared ethics committee/IRB approval is not relevant to this content

Share